Surmodics, Inc.
SRDX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,318 | -$5,209 | -$3,651 | -$3,449 |
| Dep. & Amort. | $2,103 | $2,139 | $2,083 | $2,139 |
| Deferred Tax | $0 | -$53 | -$68 | -$58 |
| Stock-Based Comp. | $1,343 | $1,364 | $1,743 | $2,079 |
| Change in WC | $3,049 | $2,448 | -$8,366 | $2,783 |
| Other Non-Cash | $228 | $260 | $365 | $164 |
| Operating Cash Flow | $1,405 | $949 | -$7,894 | $3,658 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$501 | -$319 | -$302 | -$542 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$4,432 | -$1,961 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $4,000 | $10,000 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$4,933 | -$2,280 | $3,698 | $9,458 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$1 | $64 | $105 | $553 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$28 | -$16 | -$1,308 | -$2,115 |
| Financing Cash Flow | -$29 | $48 | -$1,203 | -$1,562 |
| Forex Effect | $655 | $321 | -$571 | $260 |
| Net Chg. in Cash | -$2,902 | -$962 | -$5,970 | $11,814 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $29,183 | $30,145 | $36,115 | $24,301 |
| End Cash | $26,281 | $29,183 | $30,145 | $36,115 |
| Free Cash Flow | $904 | $630 | -$8,196 | $3,116 |